Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Sunesis Pharmaceuticals, Inc.

NASDAQ: SNSSHealthcare / Biotechnology / USA
0.9700+0.0500+5.43%Vol 168 2221Y Perf -72.38%
Mar 18th, 2019 09:45
BID0.9700 ASK0.9800
Open0.9300 Previous Close0.9200
Pre-Market0.90 After-Trading0.91
 -0.02 -2.17%  -0.01 -1.09%
Target Price
4.83 
Analyst Rating
Moderate Buy 2.00
Potencial %
419.36 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)66 
Earnings Rating
Neutral
Price Range Ratio 52wk %
22.45 
Earnings Date
7th Mar 2019

Today's Price Range

0.91000.9900

 

52wk Range

0.20003.63

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
73.58%
3 Months
148.65%
6 Months
-50.00%
1 Year
-72.38%
3 Years
-68.06%
5 Years
-97.81%

Name / TickerPriceChg.Chg.%
SNSS0.97000.05005.43
AAPL187.070.95000.51
GOOG1 178.50-5.9600-0.50
MSFT116.720.81000.70
XOM80.950.80001.00
WFC51.450.79001.56
JNJ136.84-0.7600-0.55
FB160.85-5.1300-3.09
GE10.080.12001.20
JPM107.230.68000.64
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.60
Current Ratio
1.70
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-22.90
Leverage Ratio -2.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-11 013.50
EBITDA Margin
-11 010.10
Pre-tax Profit Margin
-2 809.50
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
237
Revenue per Share
0.01
Revenue Growth 3 Years
-53.89
Revenue Growth 5 Years
-46.90

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.22-0.1627.27
Q03 2018-0.24-0.1825.00
Q02 2018-0.26-0.2023.08
Q01 2018-0.29-0.2127.59
Q04 2017-0.25-0.2116.00
Q03 2017-0.37-0.43-16.22
Q02 2017-0.76-0.4146.05
Q01 2017-0.83-0.4743.37
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.224.35Positive
3/2019 QR-0.250.00-
12/2019 FY-0.66-164.00Negative
12/2020 FY-0.83-232.00Negative
Next Report Date-
Estimated EPS Next Report-0.22
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume168 222
Shares Outstanding (in ths.)67 578
Trades Count293
Dollar Volume280 591
Avg. Volume737 698
Avg. Weekly Volume668 640
Avg. Monthly Volume647 255
Avg. Quarterly Volume740 902

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

61%39%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
1.67

There are no comments yet.

News